We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

56 hedge funds and large institutions have $47.4M invested in Osiris Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $887K

Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
56
Increased
–
Reduced
–
Closed
–
Calls
$1.26M
Puts
$887K
Net Calls
+$373K
Net Calls Change
+$373K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$9.24M +$9.64M +917,720 New
BFA
2
BlackRock Fund Advisors
California
$7.24M +$7.56M +719,262 New
BIT
3
BlackRock Institutional Trust
California
$5.55M +$5.79M +550,723 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.3M +$5.53M +526,692 New
Northern Trust
5
Northern Trust
Illinois
$2.68M +$2.8M +266,143 New
State Street
6
State Street
Massachusetts
$2.57M +$2.68M +254,768 New
HRCM
7
Hood River Capital Management
Florida
$2.54M +$2.65M +252,273 New
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$995K +$1.04M +98,764 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$983K +$1.03M +97,699 New
RA
10
Rational Advisors
New York
$826K +$862K +82,000 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$705K +$736K +70,032 New
TCIM
12
TIAA CREF Investment Management
New York
$691K +$721K +68,623 New
AllianceBernstein
13
AllianceBernstein
Tennessee
$529K +$552K +52,577 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$487K +$508K +48,340 New
CS
15
Credit Suisse
Switzerland
$468K +$488K +46,435 New
BIM
16
BlackRock Investment Management
Delaware
$451K +$471K +44,789 New
Charles Schwab
17
Charles Schwab
California
$334K +$347K +33,031 New
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$291K +$304K +28,929 New
Citadel Advisors
19
Citadel Advisors
Florida
$251K +$261K +24,850 New
State Board of Administration of Florida Retirement System
20
State Board of Administration of Florida Retirement System
Florida
$234K +$245K +23,273 New
Barclays
21
Barclays
United Kingdom
$227K +$236K +22,476 New
Allianz Asset Management
22
Allianz Asset Management
Germany
$222K +$231K +22,000 New
GCP
23
GSA Capital Partners
United Kingdom
$216K +$225K +21,457 New
RFC
24
Regions Financial Corp
Alabama
$211K +$220K +20,915 New
PCMI
25
Princeton Capital Management Inc
New Jersey
$210K +$219K +20,875 New
1
2 3

OSIR Hedge Fund Activity: Q2 2013 in Review

56 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2013, worth a combined $47.4M.

Buyers outnumbered sellers: 56 funds opened new OSIR positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $47.4M of Osiris Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 56 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.